Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Oncotarget|September 9, 2017
Correction: Deciphering the role of nuclear and cytoplasmic IKKα in skin cancerJosefa P Alameda, Miriam Gaspar, Ángel Ramírez, et al.
Journal of Translational Medicine|April 5, 2025
Genomics guiding personalized first-line immunotherapy response in lung and bladder tumorsJenifer Brea-Iglesias, María Gallardo-Gómez, Ana Oitabén, et al.
Molecular and Cellular Biology|May 31, 2018
Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and CarcinogenesisPilar Liceras-Boillos, David Jimeno, Rósula García-Navas, et al.
Oncogene|November 7, 2024
Nuclear versus cytoplasmic IKKα signaling in keratinocytes leads to opposite skin phenotypes and inflammatory responses, and a different predisposition to cancerVerónica A García-García, Josefa P Alameda, M Jesús Fernández-Aceñero, et al.
Oncotarget|October 13, 2016
IKKα regulates the stratification and differentiation of the epidermis: implications for skin cancer developmentJosefa P Alameda, Manuel Navarro, Ángel Ramírez, et al.
Molecular Biology of the Cell|October 26, 2007
Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signalingCarmen Segrelles, Marta Moral, Corina Lorz, et al.
Oncotarget|January 7, 2017
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancerCristina Segovia, Mónica Martínez-Fernández, Marta Dueñas, et al.
Cancers|July 9, 2022
Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung CancerElena Duréndez-Sáez, Silvia Calabuig-Fariñas, Susana Torres-Martínez, et al.
Stem Cell Reviews and Reports|April 9, 2010
A functional role of RB-dependent pathway in the control of quiescence in adult epidermal stem cells revealed by genomic profilingCorina Lorz, Ramón García-Escudero, Carmen Segrelles, et al.
The Oncologist|May 8, 2026
The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trialFélix Guerrero-Ramos, Carmen Gómez-Cañizo, Marta Rodríguez-Izquierdo, et al.
Pageof 11